StemCells (STEM) +23% after announcing the results of preclinical trials which showed that...

|By:, SA News Editor

StemCells (STEM) +23% after announcing the results of preclinical trials which showed that transplanting its proprietary human neural stem cells "restored memory and enhanced synaptic function in two animal models relevant to Alzheimer's disease." The data was presented at the Alzheimer's Association International Conference (AAIC 2012). (PR)